Document type

Article

Version

Accepted version

Publication date

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/196203

Nanomedicine targeting brain lipid metabolism as a feasible approach for controlling energy balance

Journal Title

Director/Tutor

Additional contribution

Journal ISSN

Volume Title

Abstract

Targeting brain lipid metabolism is a promising strategy to regulate the energy balance and fight metabolic diseases such as obesity. The development of stable platforms for selective delivery of drugs, particularly to the hypothalamus, is a challenge but a possible solution for these metabolic diseases. Attenuating fatty acid oxidation in the hypothalamus via CPT1A inhibition leads to satiety, but this target is difficult to reach in vivo with the current drugs. We propose using an advanced crosslinked polymeric micelle-type nanomedicine that can stably load the CPT1A inhibitor C75-CoA for in vivo control of the energy balance. Central adminis- tration of the nanomedicine induced a rapid attenuation of food intake and body weight in mice via regu- lation of appetite-related neuropeptides and neuronal activation of specific hypothalamic regions driving changes in the liver and adipose tissue. This nanomedicine targeting brain lipid metabolism was successful in the modulation of food intake and peripheral metabolism in mice.

Subject (English)

Citation

Citation

GARCÍA-CHICA, Jesús, et al. Nanomedicine targeting brain lipid metabolism as a feasible approach for controlling energy balance. Biomaterials Science. 2023. Vol. 9, num. 2336-2347. ISSN 2047-4830. [consulted: 9 of November of 2026]. Available at: https://hdl.handle.net/2445/196203

Export metadata

JSON - METS

Share record